SCHEMBL4733393

SCHEMBL4733393

COC(=O)c1cc(N)nc(C)c1Br

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.45
ALDH1A1 P00352 5/20 0.43
HPGD P15428 2/20 0.43
POLB P06746 1/20 0.41
GAA P10253 5/20 0.41
HSD17B10 Q99714 2/20 0.40
GLA P06280 2/20 0.40
MAPT P10636 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
ATM Q13315 1/20 0.40
TSHR P16473 1/20 0.40
CFTR P13569 1/20 0.40
ACHE P22303 2/20 0.39
ABL1 P00519 1/20 0.39
MAPK10 P53779 1/20 0.39
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31310092 0.83 KDM4E (0.49) KDM4EALDH1A1HPGDGAAHSD17B10
SCHEMBL27151963 0.83 KDM4E (0.47) KDM4EALDH1A1HPGDPOLBGAA
SCHEMBL30823904 0.83 KDM4E (0.47) KDM4EALDH1A1HPGDPOLBGAA
SCHEMBL25198877 0.82 GAA (0.46) KDM4EALDH1A1HPGDPOLBGAA
SCHEMBL29818569 0.82 GAA (0.46) KDM4EALDH1A1HPGDPOLBGAA
SCHEMBL25195692 0.82 KDM4E (0.47) KDM4EALDH1A1HPGDPOLBGAA
SCHEMBL14207376 0.80 KDM4E (0.45) KDM4EALDH1A1HPGDPOLBGAA
SCHEMBL30380295 0.80 GAA (0.47) KDM4EALDH1A1HPGDPOLBGAA
SCHEMBL4770167 0.74 GABRP (0.65) KDM4EALDH1A1HPGDGAAHSD17B10
SCHEMBL29788969 0.74 KDM4E (0.53) KDM4EALDH1A1HPGDPOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024041440-A1 TRICYCLIC HETEROCYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOF DANATLAS PHARMACEUTICALS CO., LTD. (CN) 2024-02-29 WO disclosed
WO-2023060173-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE AQUINNAH PHARMACEUTICALS, INC. (US) 2023-04-13 WO disclosed
WO-2008063625-A2 PYRIDINE COMPOUNDS AND METHODS OF THEIR USE ADOLOR CORPORATION (US) 2008-05-29 WO disclosed
WO-2008063625-A2 PYRIDINE COMPOUNDS AND METHODS OF THEIR USE ADOLOR CORPORATION (US) 2008-05-29 WO disclosed